U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C34H52N2O2
Molecular Weight 520.7889
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ANIPAMIL

SMILES

CCCCCCCCCCCCC(CCCN(C)CCC1=CC(OC)=CC=C1)(C#N)C2=CC=CC(OC)=C2

InChI

InChIKey=PHFDAOXXIZOUIX-UHFFFAOYSA-N
InChI=1S/C34H52N2O2/c1-5-6-7-8-9-10-11-12-13-14-23-34(29-35,31-19-16-21-33(28-31)38-4)24-17-25-36(2)26-22-30-18-15-20-32(27-30)37-3/h15-16,18-21,27-28H,5-14,17,22-26H2,1-4H3

HIDE SMILES / InChI
Molecular Formula C34H52N2O2
Molecular Weight 520.7889
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Approval Year

Unknown
139594
PubMed

PubMed

TitleDatePubMed
Protective effect of the new calcium antagonist anipamil against isoprenaline-induced cardionecrosis in rats.
1988 Feb
Patents

Patents

20020012704
7
Substance Class Chemical
Created
by admin
on Sat Dec 16 16:20:58 GMT 2023
Edited
by admin
on Sat Dec 16 16:20:58 GMT 2023
Record UNII
9Y54WZV1CJ
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ANIPAMIL
INN   MART.   WHO-DD  
INN  
Official Name English
BENZENEACETONITRILE, .ALPHA.-DODECYL-3-METHOXY-.ALPHA.-(3-((2-(3-METHOXYPHENYL)ETHYL)METHYLAMINO)PROPYL)-
Systematic Name English
anipamil [INN]
Common Name English
ANIPAMIL [MART.]
Common Name English
Anipamil [WHO-DD]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C333
Created by admin on Sat Dec 16 16:20:58 GMT 2023 , Edited by admin on Sat Dec 16 16:20:58 GMT 2023
Code System Code Type Description
MESH
C045313
Created by admin on Sat Dec 16 16:20:58 GMT 2023 , Edited by admin on Sat Dec 16 16:20:58 GMT 2023
PRIMARY
PUBCHEM
54966
Created by admin on Sat Dec 16 16:20:58 GMT 2023 , Edited by admin on Sat Dec 16 16:20:58 GMT 2023
PRIMARY
INN
5316
Created by admin on Sat Dec 16 16:20:58 GMT 2023 , Edited by admin on Sat Dec 16 16:20:58 GMT 2023
PRIMARY
ECHA (EC/EINECS)
280-213-5
Created by admin on Sat Dec 16 16:20:58 GMT 2023 , Edited by admin on Sat Dec 16 16:20:58 GMT 2023
PRIMARY
FDA UNII
9Y54WZV1CJ
Created by admin on Sat Dec 16 16:20:58 GMT 2023 , Edited by admin on Sat Dec 16 16:20:58 GMT 2023
PRIMARY
NCI_THESAURUS
C76578
Created by admin on Sat Dec 16 16:20:58 GMT 2023 , Edited by admin on Sat Dec 16 16:20:58 GMT 2023
PRIMARY
CAS
83200-10-6
Created by admin on Sat Dec 16 16:20:58 GMT 2023 , Edited by admin on Sat Dec 16 16:20:58 GMT 2023
PRIMARY
SMS_ID
100000086946
Created by admin on Sat Dec 16 16:20:58 GMT 2023 , Edited by admin on Sat Dec 16 16:20:58 GMT 2023
PRIMARY
ChEMBL
CHEMBL2104548
Created by admin on Sat Dec 16 16:20:58 GMT 2023 , Edited by admin on Sat Dec 16 16:20:58 GMT 2023
PRIMARY
EVMPD
SUB05516MIG
Created by admin on Sat Dec 16 16:20:58 GMT 2023 , Edited by admin on Sat Dec 16 16:20:58 GMT 2023
PRIMARY
EPA CompTox
DTXSID70868699
Created by admin on Sat Dec 16 16:20:58 GMT 2023 , Edited by admin on Sat Dec 16 16:20:58 GMT 2023
PRIMARY
WIKIPEDIA
ANIPAMIL
Created by admin on Sat Dec 16 16:20:58 GMT 2023 , Edited by admin on Sat Dec 16 16:20:58 GMT 2023
PRIMARY
Related Record Type Details
Structure of ANIPAMIL HYDROCHLORIDE
SALT/SOLVATE -> PARENT
Structure of ANIPAMIL, (-)-
ENANTIOMER -> RACEMATE
Structure of ANIPAMIL, (+)-
ENANTIOMER -> RACEMATE
Related Record Type Details
Structure of ANIPAMIL
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966